drugset / Trial / NCT00959803

Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects.

NCT00959803

Phase 1 Completed 17 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

This study is designed to investigate the safety, tolerability, and pharmacokinetics of PF-04447943 after single and multiple-dose administration to healthy young adult and elderly Japanese subjects, respectively.

Timeline

Start
2009-08
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject EDELINONTRINE Small molecule 3 mg Oral
Subject EDELINONTRINE Small molecule 10 mg Oral
Subject EDELINONTRINE Small molecule 25 mg Oral

Indications

No indication recorded.